Literature DB >> 3997135

Adrenal pheochromocytoma: a clinicopathologic review of 60 cases.

L J Medeiros, B C Wolf, K Balogh, M Federman.   

Abstract

The clinical and pathologic features of 60 adrenal pheochromocytomas were reviewed in an attempt to evaluate the utility of histopathologic evaluation in predicting the prognosis for these tumors. Fifty-five tumors were benign, and five were malignant, characterized either by histologically proved metastases or by extensive local invasion. The prevalence of all parameters studied was compared between the benign and malignant groups. Three differences were observed between the benign and malignant tumors. The malignant tumors were usually larger, had extensive areas of necrosis, and were composed of small cells. In agreement with the results of previous investigations, the morphologic criteria generally used to predict the behavior of tumors, i.e., nuclear atypia, capsular and vascular invasion, and mitotic activity, were of little value in predicting the behavior of adrenal pheochromocytomas. Fifteen tumors, all of which had membrane-bound, cytoplasmic granules, were examined electron microscopically. A minority of these tumors fit the classic descriptions of "norepinephrine" and "epinephrine" granules reported in the literature, while the majority of the granules had features of both types, precluding definitive classification. As a result of these observations, the currently accepted criteria of norepinephrine and epinephrine granules were questioned. A review of the literature cast further doubt on the existence of a correlation between granule content and morphology. Both of the patients with locally invasive malignant tumors were alive and well eight and 28 years following diagnosis and radical surgery. In contrast, the patients with histologically proved distant metastases died within one year of diagnosis. These observations suggest that locally invasive tumors may not have the same dismal prognosis as adrenal pheochromocytomas that have metastasized.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3997135     DOI: 10.1016/s0046-8177(85)80107-6

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  31 in total

1.  Malignant pheochromocytoma: new malignancy criteria.

Authors:  Pierre de Wailly; Luigi Oragano; Francois Radé; Anthony Beaulieu; Vincent Arnault; Pierre Levillain; Jean Louis Kraimps
Journal:  Langenbecks Arch Surg       Date:  2011-11-09       Impact factor: 3.445

2.  Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine 131 metaiodobenzylguanidine.

Authors:  F A Khafagi; B Shapiro; M Fischer; J C Sisson; R Hutchinson; W H Beierwaltes
Journal:  Eur J Nucl Med       Date:  1991

3.  The effect of catecholamines on the glucose uptake in brown adipose tissue demonstrated by (18)F-FDG PET/CT in a patient with adrenal pheochromocytoma.

Authors:  Lilian Yuri Itaya Yamaga; Anneliese Fischer Thom; Jairo Wagner; Ronaldo Hueb Baroni; Jairo Tabacow Hidal; Marcelo Gusmão Funari
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-02       Impact factor: 9.236

4.  Ultrastructure of pheochromocytoma: undescribed morphologic features.

Authors:  A Beiras Fernandez; A Kornberger; M Fraga; C F Vahl; A Beiras
Journal:  Virchows Arch       Date:  2017-04-20       Impact factor: 4.064

5.  Dna ploidy of pheochromocytoma on cytology specimen by image analysis.

Authors:  Noriko Kimura; Mika Watanabe; Tsuneo Ookuma; Wakako Miura; Takao Noshiro; Yukio Miura; Hiroshi Nagura
Journal:  Endocr Pathol       Date:  1994-09       Impact factor: 3.943

6.  Ki-67 is an indicator of progression of neuroendocrine tumors.

Authors:  Noriko Kimura; Wakako Miura; Takao Noshiro; Yukio Miura; Tsuneo Ookuma; Hiroshi Nagura
Journal:  Endocr Pathol       Date:  1994-12       Impact factor: 3.943

7.  Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors.

Authors:  Noriko Kimura; Toshiya Watanabe; Takao Noshiro; Soichiro Shizawa; Yukio Miura
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 8.  Differential diagnosis of pheochromocytomas and paragangliomas.

Authors:  A M McNichol
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 9.  Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification.

Authors:  Graeme Eisenhofer; Arthur S Tischler; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2012-03       Impact factor: 3.943

10.  Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques.

Authors:  Nobue Kumaki; Hiroshi Kajiwara; Kaori Kameyama; Ronald A DeLellis; Sylvia L Asa; R Yoshiyuki Osamura; Hiroshi Takami
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.